IBDEI0K7 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27220,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,27221,0)
 ;;=365.01^^186^1708^30
 ;;^UTILITY(U,$J,358.3,27221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27221,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,27221,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,27221,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,27222,0)
 ;;=365.71^^186^1708^24
 ;;^UTILITY(U,$J,358.3,27222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27222,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,27222,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,27222,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,27223,0)
 ;;=365.72^^186^1708^25
 ;;^UTILITY(U,$J,358.3,27223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27223,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,27223,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,27223,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,27224,0)
 ;;=365.73^^186^1708^28
 ;;^UTILITY(U,$J,358.3,27224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27224,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,27224,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,27224,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,27225,0)
 ;;=362.51^^186^1708^1
 ;;^UTILITY(U,$J,358.3,27225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27225,1,3,0)
 ;;=3^AMD,Dry
 ;;^UTILITY(U,$J,358.3,27225,1,4,0)
 ;;=4^362.51
 ;;^UTILITY(U,$J,358.3,27225,2)
 ;;=^268636
 ;;^UTILITY(U,$J,358.3,27226,0)
 ;;=362.52^^186^1708^2
 ;;^UTILITY(U,$J,358.3,27226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27226,1,3,0)
 ;;=3^AMD,Wet/Exudative
 ;;^UTILITY(U,$J,358.3,27226,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,27226,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,27227,0)
 ;;=362.04^^186^1708^14
 ;;^UTILITY(U,$J,358.3,27227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27227,1,3,0)
 ;;=3^DM Mild NPDR
 ;;^UTILITY(U,$J,358.3,27227,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,27227,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,27228,0)
 ;;=362.05^^186^1708^15
 ;;^UTILITY(U,$J,358.3,27228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27228,1,3,0)
 ;;=3^DM Moderate NPDR
 ;;^UTILITY(U,$J,358.3,27228,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,27228,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,27229,0)
 ;;=362.06^^186^1708^17
 ;;^UTILITY(U,$J,358.3,27229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27229,1,3,0)
 ;;=3^DM Severe NPDR
 ;;^UTILITY(U,$J,358.3,27229,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,27229,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,27230,0)
 ;;=362.02^^186^1708^16
 ;;^UTILITY(U,$J,358.3,27230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27230,1,3,0)
 ;;=3^DM PDR
 ;;^UTILITY(U,$J,358.3,27230,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,27230,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,27231,0)
 ;;=379.39^^186^1708^45
 ;;^UTILITY(U,$J,358.3,27231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27231,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,27231,1,4,0)
 ;;=4^379.39
 ;;^UTILITY(U,$J,358.3,27231,2)
 ;;=^87515
 ;;^UTILITY(U,$J,358.3,27232,0)
 ;;=367.9^^186^1708^18
 ;;^UTILITY(U,$J,358.3,27232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27232,1,3,0)
 ;;=3^Disorder of Refraction
 ;;^UTILITY(U,$J,358.3,27232,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,27232,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,27233,0)
 ;;=373.2^^186^1708^35
 ;;^UTILITY(U,$J,358.3,27233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27233,1,3,0)
 ;;=3^Meibomianitis
 ;;^UTILITY(U,$J,358.3,27233,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,27233,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,27234,0)
 ;;=V58.69^^186^1708^33
 ;;^UTILITY(U,$J,358.3,27234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27234,1,3,0)
 ;;=3^Long Term Use of Medication
 ;;^UTILITY(U,$J,358.3,27234,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,27234,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,27235,0)
 ;;=379.24^^186^1708^51
 ;;^UTILITY(U,$J,358.3,27235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27235,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,27235,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,27235,2)
 ;;=^88242
 ;;^UTILITY(U,$J,358.3,27236,0)
 ;;=V80.2^^186^1708^47
 ;;^UTILITY(U,$J,358.3,27236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27236,1,3,0)
 ;;=3^Screening for Eye Condition
 ;;^UTILITY(U,$J,358.3,27236,1,4,0)
 ;;=4^V80.2
 ;;^UTILITY(U,$J,358.3,27236,2)
 ;;=^295685
 ;;^UTILITY(U,$J,358.3,27237,0)
 ;;=V70.5^^186^1708^48
 ;;^UTILITY(U,$J,358.3,27237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27237,1,3,0)
 ;;=3^Screening,Occupational
 ;;^UTILITY(U,$J,358.3,27237,1,4,0)
 ;;=4^V70.5
 ;;^UTILITY(U,$J,358.3,27237,2)
 ;;=^295595
 ;;^UTILITY(U,$J,358.3,27238,0)
 ;;=365.11^^186^1708^27
 ;;^UTILITY(U,$J,358.3,27238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27238,1,3,0)
 ;;=3^Glaucoma Primary Open Angle
 ;;^UTILITY(U,$J,358.3,27238,1,4,0)
 ;;=4^365.11
 ;;^UTILITY(U,$J,358.3,27238,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,27239,0)
 ;;=365.70^^186^1708^29
 ;;^UTILITY(U,$J,358.3,27239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27239,1,3,0)
 ;;=3^Glaucoma Stage NOS
 ;;^UTILITY(U,$J,358.3,27239,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,27239,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,27240,0)
 ;;=365.74^^186^1708^23
 ;;^UTILITY(U,$J,358.3,27240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27240,1,3,0)
 ;;=3^Glaucoma Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,27240,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,27240,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,27241,0)
 ;;=53600^^187^1709^4^^^^1
 ;;^UTILITY(U,$J,358.3,27241,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27241,1,2,0)
 ;;=2^53600
 ;;^UTILITY(U,$J,358.3,27241,1,3,0)
 ;;=3^Dilation, urethral w/o cysto, init
 ;;^UTILITY(U,$J,358.3,27242,0)
 ;;=53601^^187^1709^3^^^^1
 ;;^UTILITY(U,$J,358.3,27242,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27242,1,2,0)
 ;;=2^53601
 ;;^UTILITY(U,$J,358.3,27242,1,3,0)
 ;;=3^Dilation, urethral subsequent
 ;;^UTILITY(U,$J,358.3,27243,0)
 ;;=53620^^187^1709^1^^^^1
 ;;^UTILITY(U,$J,358.3,27243,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27243,1,2,0)
 ;;=2^53620
 ;;^UTILITY(U,$J,358.3,27243,1,3,0)
 ;;=3^Dilation, filiform
 ;;^UTILITY(U,$J,358.3,27244,0)
 ;;=53621^^187^1709^2^^^^1
 ;;^UTILITY(U,$J,358.3,27244,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27244,1,2,0)
 ;;=2^53621
 ;;^UTILITY(U,$J,358.3,27244,1,3,0)
 ;;=3^Dilation, filiform, subsequent
 ;;^UTILITY(U,$J,358.3,27245,0)
 ;;=51720^^187^1710^5^^^^1
 ;;^UTILITY(U,$J,358.3,27245,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27245,1,2,0)
 ;;=2^51720
 ;;^UTILITY(U,$J,358.3,27245,1,3,0)
 ;;=3^Bladder Instill Of Anticarc.
 ;;^UTILITY(U,$J,358.3,27246,0)
 ;;=51700^^187^1710^6^^^^1
 ;;^UTILITY(U,$J,358.3,27246,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27246,1,2,0)
 ;;=2^51700
 ;;^UTILITY(U,$J,358.3,27246,1,3,0)
 ;;=3^Bladder Irrigation
 ;;^UTILITY(U,$J,358.3,27247,0)
 ;;=55870^^187^1710^13^^^^1
 ;;^UTILITY(U,$J,358.3,27247,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27247,1,2,0)
 ;;=2^55870
 ;;^UTILITY(U,$J,358.3,27247,1,3,0)
 ;;=3^Electroejaculation
 ;;^UTILITY(U,$J,358.3,27248,0)
 ;;=54055^^187^1710^16^^^^1
 ;;^UTILITY(U,$J,358.3,27248,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27248,1,2,0)
 ;;=2^54055
 ;;^UTILITY(U,$J,358.3,27248,1,3,0)
 ;;=3^Fulgurate Penile Wart/Lesions, Simple
 ;;^UTILITY(U,$J,358.3,27249,0)
 ;;=54220^^187^1710^19^^^^1
 ;;^UTILITY(U,$J,358.3,27249,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27249,1,2,0)
 ;;=2^54220
 ;;^UTILITY(U,$J,358.3,27249,1,3,0)
 ;;=3^Irrigation for Priapism
 ;;^UTILITY(U,$J,358.3,27250,0)
 ;;=50398^^187^1710^22^^^^1
 ;;^UTILITY(U,$J,358.3,27250,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27250,1,2,0)
 ;;=2^50398
 ;;^UTILITY(U,$J,358.3,27250,1,3,0)
 ;;=3^Nephrostomy Tube Change
 ;;^UTILITY(U,$J,358.3,27251,0)
 ;;=51600^^187^1710^10^^^^1
 ;;^UTILITY(U,$J,358.3,27251,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27251,1,2,0)
 ;;=2^51600
 ;;^UTILITY(U,$J,358.3,27251,1,3,0)
 ;;=3^Cystogram
 ;;^UTILITY(U,$J,358.3,27252,0)
 ;;=11000^^187^1710^12^^^^1
 ;;^UTILITY(U,$J,358.3,27252,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27252,1,2,0)
 ;;=2^11000
 ;;^UTILITY(U,$J,358.3,27252,1,3,0)
 ;;=3^Debride Infected Skin up to 10%
 ;;^UTILITY(U,$J,358.3,27253,0)
 ;;=11001^^187^1710^11^^^^1
 ;;^UTILITY(U,$J,358.3,27253,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27253,1,2,0)
 ;;=2^11001
 ;;^UTILITY(U,$J,358.3,27253,1,3,0)
 ;;=3^Debride Inf Skin, ea addl 10%
 ;;^UTILITY(U,$J,358.3,27254,0)
 ;;=J9031^^187^1710^1^^^^1
 ;;^UTILITY(U,$J,358.3,27254,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27254,1,2,0)
 ;;=2^J9031
 ;;^UTILITY(U,$J,358.3,27254,1,3,0)
 ;;=3^     BCG
 ;;^UTILITY(U,$J,358.3,27255,0)
 ;;=J9340^^187^1710^3^^^^1
 ;;^UTILITY(U,$J,358.3,27255,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27255,1,2,0)
 ;;=2^J9340
 ;;^UTILITY(U,$J,358.3,27255,1,3,0)
 ;;=3^     Thioplex, per 15mg
 ;;^UTILITY(U,$J,358.3,27256,0)
 ;;=J1212^^187^1710^2^^^^1
 ;;^UTILITY(U,$J,358.3,27256,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27256,1,2,0)
 ;;=2^J1212
 ;;^UTILITY(U,$J,358.3,27256,1,3,0)
 ;;=3^     DMSO, per 50ml
 ;;^UTILITY(U,$J,358.3,27257,0)
 ;;=51701^^187^1710^7^^^^1
 ;;^UTILITY(U,$J,358.3,27257,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27257,1,2,0)
 ;;=2^51701
 ;;^UTILITY(U,$J,358.3,27257,1,3,0)
 ;;=3^Catherization for Residual Urine
 ;;^UTILITY(U,$J,358.3,27258,0)
 ;;=51702^^187^1710^15^^^^1
 ;;^UTILITY(U,$J,358.3,27258,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27258,1,2,0)
 ;;=2^51702
 ;;^UTILITY(U,$J,358.3,27258,1,3,0)
 ;;=3^Foley Catheterization
 ;;^UTILITY(U,$J,358.3,27259,0)
 ;;=51703^^187^1710^8^^^^1
 ;;^UTILITY(U,$J,358.3,27259,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27259,1,2,0)
 ;;=2^51703
 ;;^UTILITY(U,$J,358.3,27259,1,3,0)
 ;;=3^Catheterization, Complex (MD)
 ;;^UTILITY(U,$J,358.3,27260,0)
 ;;=54162^^187^1710^21^^^^1
 ;;^UTILITY(U,$J,358.3,27260,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27260,1,2,0)
 ;;=2^54162
 ;;^UTILITY(U,$J,358.3,27260,1,3,0)
 ;;=3^Lysis Penil Circumic Lesion
